tiprankstipranks
Trending News
More News >
Percheron Therapeutics Limited (AU:PER)
:PER
Australian Market
Advertisement

Percheron Therapeutics (PER) Income Statement

Compare
13 Followers

Percheron Therapeutics Income Statement

Last quarter (Q4 2025), Percheron Therapeutics's total revenue was AU$0.00, a decrease of ― from previous quarter. In Q4, Percheron Therapeutics's net income was AU$-6.39M. See Percheron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Gross Profit
AU$ -67.98KAU$ -79.42KAU$ -95.20KAU$ -89.22KAU$ -103.32K
Operating Expenses
AU$ 16.64MAU$ 14.80MAU$ 13.25MAU$ 7.52MAU$ 8.58M
Depreciation and Amortization
AU$ 67.98KAU$ 79.42KAU$ 95.20KAU$ 89.22KAU$ 103.32K
EBITDA
AU$ -16.27MAU$ -11.84MAU$ -13.25MAU$ -7.52MAU$ -8.58M
Operating Income
AU$ -16.71MAU$ -14.88MAU$ -13.34MAU$ -7.61MAU$ -8.68M
Other Income/Expenses
AU$ 356.16KAU$ 608.89KAU$ 385.30KAU$ 21.52KAU$ 44.88K
Pretax Income
AU$ -16.35MAU$ -14.27MAU$ -12.96MAU$ -7.59MAU$ -8.64M
Net Income
AU$ -14.92MAU$ -11.92MAU$ -11.38MAU$ -5.81MAU$ -8.06M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
1.02B 669.03M 669.03M 634.29M 540.98M
Weighted Average Shares Outstanding (Diluted)
1.02B 669.03M 669.03M 634.29M 540.98M
Currency in AUD

Percheron Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis